Abid Ullah Shah

The paper analyzes respiratory BCoV isolates from U.S. cattle 2020-2025, identifying GIIb strains and amino acid substitutions suggesting ongoing viral evolution.

This study isolates and characterizes a new BCoV isolate, identifying mutations in the spike protein and deletions in the nucleocapsid gene, with implications for viral pathogenesis and immune evasion.

This study infects bovine PBMCs and spleen cells with BCoV, showing differential cytokine gene expression and effects on T-cell populations that may support virus replication.

This study uses in-silico tools to identify antiviral compounds targeting FIPV-MPro, finding N3, Sofosbuvir, and methotrexate as top inhibitors.

This study identifies miRNA-16a as a host factor that inhibits BCoV replication by targeting Furin and enhances immune response, suggesting its potential as an antiviral therapy.